Group 1 for Cardiometabolic Risk Factors in Adult Wheelchair Users
Study Summary
This trial tests if an exercise program can reverse heart, blood, and blood vessel health risks in adult wheelchair users. It also tests if an online version can help them maintain physical activity.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
8 Primary · 7 Secondary · Reporting Duration: 36 Weeks
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Group 2
1 of 2
Group 1
1 of 2
Active Control
Experimental Treatment
132 Total Participants · 2 Treatment Groups
Primary Treatment: Group 1 · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 89 · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Does this experimental study still have vacancies for participants?
"Per clinicaltrials.gov, this medical trial is not presently accepting candidates as the last update was made on October 31st of 2022. However, there are other studies actively looking for participants at present." - Anonymous Online Contributor
Who would be best suited to engage in this medical investigation?
"This medical trial requires 132 participants who are adults with cardiometabolic risk factors, and aged between 18-89 years old. Wheelchair users are eligible to apply." - Anonymous Online Contributor
What is the primary objective of this experiment?
"This 24-week trial's primary endpoint is weight, while secondary endpoints are cardiovascular capacity (Polar heart rate monitor), perceived exertion (Borg RPE Scale), and pulmonary function (Spirometry)." - Anonymous Online Contributor
Are adults above the age of 25 included in this research?
"This clinical trial is accepting participants over the age of consent and under 89 years old." - Anonymous Online Contributor